Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Revenue (2020 - 2025)

Historic Revenue for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $19.5 million.

  • SOPHiA GENETICS's Revenue rose 2276.54% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 1365.99%. This contributed to the annual value of $65.2 million for FY2024, which is 449.25% up from last year.
  • Per SOPHiA GENETICS's latest filing, its Revenue stood at $19.5 million for Q3 2025, which was up 2276.54% from $18.3 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Revenue ranged from a high of $19.5 million in Q3 2025 and a low of $9.0 million during Q1 2021
  • Moreover, its 5-year median value for Revenue was $15.1 million (2023), whereas its average is $14.3 million.
  • Within the past 5 years, the most significant YoY rise in SOPHiA GENETICS's Revenue was 14441729.91% (2021), while the steepest drop was 9982.8% (2021).
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Revenue stood at $10.9 million in 2021, then grew by 22.37% to $13.4 million in 2022, then grew by 27.38% to $17.0 million in 2023, then increased by 4.02% to $17.7 million in 2024, then increased by 9.75% to $19.5 million in 2025.
  • Its Revenue stands at $19.5 million for Q3 2025, versus $18.3 million for Q2 2025 and $17.8 million for Q1 2025.